Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.48 → 3.41 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LARK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Return capital to shareholders via dividends | A supporting condition in Landmark Bancorp Inc/Manhattan KS's published investment case. The stated target is Cash dividend >= $0.21 per share. | Intact | Dividend per share falls below $0.21 in the next four quarters | Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
LARK is a smaller-cap financial company with a relationship-banking growth thesis, rather than a clear turnaround story. Its long-term thesis is intact, and recent performance has strengthened, though management execution is mixed on expense discipline.
The evidence describes LARK as cheap versus peers, with a small negative expectations gap, suggesting expectations are not demanding. The priced-in assessment is justified and fragility is low, so the evidence does not point to unusually fragile expectations.
Near term, earnings have been strong: nine-month net earnings rose to $15.9 million from $14.0 million, and third-quarter net interest income increased from the prior quarter. However, loans and deposits declined during the quarter, while expenses rose year over year and the efficiency ratio was 63.0%, leaving progress on expense control mixed.
The near-term thesis would weaken if LARK cuts guidance on its next call; its smaller size and history of a deep miss add some risk, although the current miss-risk assessment is low. The sector backdrop also matters: continued earnings strength at sector peers could support momentum, while rate cuts from the current 3.88% level would weigh on financial companies under the scenario evidence.
For the next 1 to 3 years, LARK’s thesis rests on sustaining relationship-based growth while controlling expenses and stabilizing loans and deposits. Recent results support the thesis, but execution and interest-rate conditions remain important swing factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 2 supplied quarters. Management reported: “Stockholders’ equity decreased to $160.3 million (book value of $26.24 per share) as of September 30, 2026, from $166.9 million (book value of $27.35 per share) as of June 30, 2026.” “|| ● | Tangible common equity to assets (1) was 8.09% as of September 30, 2026, compared to 8.44% as of June 30, 2026 and 7.66% as of September 30, 2025.”
Sustain strong operating income and cash from operations | Operating income and cash flow are strong, reaching $6.32 million and $6.83 million respectively in 2026-Q1. | Broken | Operating income or cash flow falls below $5.35 million or $6.83 million respectively over the next four quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain consistent profitability and earnings per share growth | Earnings per share remain stable at $0.83 in 2026-Q1. | Intact | Net income or EPS falls below $4.40 million or $0.83 per share respectively over the next four quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.45 → $3.41 · observed estimates
Unavailable → $0.08B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.45 | Unavailable | 1 / 0 |
| 2026-07-25 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-07-26 | $3.45 | Unavailable | 1 / 0 |
| 2026-07-27 | $3.45 | Unavailable | 1 / 0 |
| 2026-07-28 | $3.45 | Unavailable | 1 / 0 |
| 2026-07-29 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-07-30 | $3.45 | Unavailable | 1 / 0 |
| 2026-07-31 | $3.45 | Unavailable | 1 / 0 |
| 2026-08-01 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-02 | $3.45 | Unavailable | 1 / 0 |
| 2026-08-03 | $3.45 | Unavailable | 1 / 0 |
| 2026-08-04 | $3.45 | Unavailable | 1 / 0 |
| 2026-08-05 | $3.48 | Unavailable | 1 / 0 |
| 2026-08-06 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-07 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-08 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-09 | $3.48 | Unavailable | 1 / 0 |
| 2026-08-10 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-12 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-13 | $3.48 | Unavailable | 1 / 0 |
| 2026-08-14 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-15 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-16 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-17 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-18 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-19 | $3.45 | $89,632,770 | 1 / 1 |
| 2026-08-20 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-21 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-22 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-23 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-24 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-25 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-26 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-27 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-28 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-29 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-30 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-08-31 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-01 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-02 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-03 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-04 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-05 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-06 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-07 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-08 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-09 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-10 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-11 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-12 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-13 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-14 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-15 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-16 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-17 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-18 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-19 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-20 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-21 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-22 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-23 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-24 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-25 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-26 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-27 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-28 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-29 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-09-30 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-01 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-02 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-03 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-04 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-05 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-06 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-07 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-08 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-09 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-10 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-11 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-12 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-13 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-14 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-15 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-16 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-17 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-18 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-19 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-20 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-21 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-22 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-23 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-24 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-25 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-26 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-27 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-28 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-29 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-30 | $3.48 | $77,900,000 | 1 / 1 |
| 2026-10-31 | $3.41 | $77,900,000 | 1 / 1 |
| 2026-11-01 | $3.41 | $77,900,000 | 1 / 1 |
| 2026-11-02 | $3.41 | $77,900,000 | 1 / 1 |
| 2026-11-03 | $3.41 | $77,900,000 | 1 / 1 |
| 2026-11-04 | $3.41 | $80,000,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.